Genetics of Colorectal Cancer (PDQ®): Genetics - Health Professional Information [NCI] - Changes to This Summary (02 / 28 / 2013)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.IntroductionUpdated statistics with estimated new cases and deaths for 2013 (cited American Cancer Society as reference 1).Added text to state that even in Lynch syndrome (LS), a hereditary form of colon cancer, cigarette smoking has been identified as a risk factor for the development of colorectal adenomas (cited Winkels et al. as reference 66).Colon Cancer GenesRevised text to state that a variety of LS-associated mutations in MSH2 and MLH1 have been identified; these include founder mutations in the Ashkenazi Jewish, Finnish, Portuguese, and German American populations (cited Pinheiro et al. and Tomsic et al. as references 31 and 32, respectively).Added De novo mutation rate as a new subsection.Major Genetic SyndromesAdded Khan et al. as reference 251.Added text to state that one study of
Pituitary Tumors Treatment (PDQ®): Treatment - Patient Information [NCI] - nci_ncicdr0000579645-nci-header
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Pituitary Tumors Treatment
Hypercalcemia (PDQ®): Supportive care - Health Professional Information [NCI] - About This PDQ Summary
PURPOSE OF THIS SUMMARY This PDQ cancer information summary for health professionals provides comprehensive,peer-reviewed,evidence-based information about the pathophysiology and treatment of hypercalcemia. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions. ...
Sleep Disorders (PDQ®): Supportive care - Patient Information [NCI] - About PDQ
PDQ IS A COMPREHENSIVE CANCER DATABASE AVAILABLE ON NCI'S WEB SITE. PDQ is the National Cancer Institute's (NCI's) comprehensive cancer information database. Most of the information contained in PDQ is available online at NCI's Web site. PDQ is provided as a service of the NCI. The NCI is part of the National Institutes of Health,the federal government's focal point for biomedical research. ...
Hydrazine Sulfate (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - Evaluation of CAM Approaches
It is important that the same rigorous scientific evaluation used to assess conventional approaches be used to evaluate CAM therapies. The National Cancer Institute (NCI) and the National Center for Complementary and Alternative Medicine (NCCAM) are sponsoring a number of clinical trials (research studies) at medical centers to evaluate CAM therapies for cancer. Conventional approaches to ...
Transitional Care Planning (PDQ®): Supportive care - Patient Information [NCI] - Special Considerations
CARING FOR A PATIENT AT HOME CAN INCREASE THE PHYSICAL AND EMOTIONAL BURDENS ON THE PATIENT'S CAREGIVERS. The stress and responsibility of in-home care can be hard on family relationships and should be carefully considered. Day-to-day routines may change for everyone. Many families have trouble getting used to the role changes that result. Patients and families may be referred to counseling ...
Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Changes to This Summary (11 / 21 / 2012)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.General InformationAdded Louis et al. as reference 2.Revised text to state that for a full description of the classification of nervous system tumors and a link to the corresponding treatment summary for each type of brain tumor, refer to the PDQ summary on Childhood Brain and Spinal Cord Tumors Treatment Overview.The Predictors of Outcome subsection was extensively revised.Cellular Classification of Central Nervous System (CNS) Embryonal TumorsAdded Taylor et al. as reference 27.Added text about the characteristics of Gorlin syndrome, including the associated mutations and diseases, predisposition to basal cell carcinomas, and the diagnostic features (cited Brugières et al. and Pastorino et al. as references 28 and 29, respectively).This summary is written and maintained by the PDQ Pediatric
714-X (PDQ®): Complementary and alternative medicine - Health Professional Information [NCI] - History
Little documentation exists regarding the development of 714-X and its mechanism of action. It appears to have been developed in the 1960s on the basis of earlier studies that used a high-magnification,dark-field microscope called a somatoscope. Reviewed in [ 1,2 ] With the somatoscope,researchers were able to examine living cells in samples of fresh blood and tissue taken from healthy ...
Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®): Treatment - Patient Information [NCI] - Changes to This Summary (02 / 01 / 2013)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.Editorial changes were made to this summary.
Childhood Liver Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage Information
Postsurgical staging A staging system based on postsurgical extent of tumor and surgical resectability has been used in the United States to group children with liver cancer. This staging system is used to determine treatment.[ 1,2,3,4 ] Children diagnosed with stage I and stage II hepatoblastoma have a cure rate of greater than 90% compared with 60% for stage III and approximately 20% for ...